Table 2.
Comparison between patients with and without EV
| Characteristic | EV (+) (n = 39) | EV (−) (n = 191) | P value |
|---|---|---|---|
| Age (years) | 61 (13–90) | 63 (10–87) | 0.553 |
| Male gender | 25 (64) | 88 (46) | 0.040 |
| Body mass index (kg/m2) | 24.5 (17.3–41.1) | 22.7 (11.9–41.0) | 0.037 |
| Etiology | |||
| NAFLD/NASH | 7 (18) | 50 (26) | 0.378 |
| HBV | 10 (26) | 37 (19) | 0.377 |
| PBC | 5 (13) | 37 (19) | 0.461 |
| ALD | 10 (26) | 13 (7) | 0.001 |
| AIH | 0 (0) | 15 (8) | 0.146 |
| Other | 7 (18) | 39 (20) | 0.895 |
| Platelet count (×109/l) | 99 (34–683) | 197 (14–713) | 0.013 |
| AST (IU/l) | 33 (15–146) | 29 (6–1261) | 0.194 |
| ALT (IU/l) | 25 (8–123) | 28 (6–1246) | 0.196 |
| Albumin (g/dl) | 3.7 (2.7–4.6) | 4.2 (1.4–4.9) | 0.005 |
| T.Bil (mg/dl) | 1.2 (0.4–7.5) | 0.7 (0.2–24.2) | <0.001 |
| PT% | 74 (27–95) | 95 (24–128) | <0.001 |
| LS (kPa) | 10.0 (3.5–75.0) | 5.3 (1.5–75.0) | <0.001 |
| Spleen size (cm) | 11.4 (6.1–24.0) | 8.6 (3.9–14.8) | <0.001 |
| LSPS | 1.7 (0.1–20.0) | 0.2 (0.0–6.4) | <0.001 |
| APRI | 1.4 (0.1–4.8) | 0.5 (0.1–33.7) | <0.001 |
| FIB-4 | 5.7 (0.2–12.0) | 1.8 (0.1–25.5) | <0.001 |
| Platelet-to-spleen ratio | 770 (220–5991) | 2201 (166–7809) | <0.001 |
Values are expressed as median (range, minimum–maximum) or n (%)